Highlander Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$839	Hold	20	–	–	﹤0.01%	883
2023 Q4	$793	Hold	20	–	–	﹤0.01%	914
2023 Q3	$1K	Buy	+20	New	+$1K	﹤0.01%	859
2014 Q4	–	Sell	-467	Closed	-$90.7K	–	850
2014 Q3	$90.7K	Buy	+467	New	+$90.7K	0.09%	250